ArticleJournal of arthropod-borne diseases2025
Emerging Cutaneous Leishmaniasis Caused by
Article in Journal of arthropod-borne diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Leishmaniasis is a neglected tropical disease transmitted by vectors, ranking among the top 10 infectious diseases globally in terms of morbidity and mortality. The cutaneous form (CL) is the most common and is endemic in 19 of Iran's 31 provinces. In non-endemic regions, however, both physician familiarity and patient encounters with the disease are rare. Methods: This study reports a case of CL in a nine-year-old boy from Sardasht County, West Azerbaijan Province, a non-endemic area for CL in Iran and with no history of travel to endemic areas. The patient presented with purulent wounds on his hands and feet that did not respond to broad-spectrum antibiotics. Diagnosis was confirmed by identifying the vacuolated amastigote forms of Results: The parasite was identified as Conclusion: This case highlights the need for rapid and accurate diagnosis, effective treatment, and ongoing surveil-lance to prevent the emergence of leishmaniasis in non-endemic regions. More attention must be paid to this disease by the healthcare system and physicians, even in non-endemic areas.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.